NCT03295201 Clinical Effects of Exercise Program Added to Pulmonary Rehabilitation in Patients With Cystic Fibrosis Status COMPLETED Phase NA
NCT03285100 The Effects of Discontinuation of Vitamin K Antagonists on the Rate of Elastin Degradation Status UNKNOWN Phase N/A
NCT03278314 Tezacaftor/Ivacaftor Combination Therapy Expanded Access Program for Patients 12 Years of Age and Older With Cystic Fibrosis Status APPROVED_FOR_MARKETING Phase N/A
NCT03277196 A Study to Evaluate the Safety of Long-term Ivacaftor Treatment in Participants With Cystic Fibrosis Who Are Less Than 24 Months of Age at Treatment Initiation and Have an Approved Ivacaftor-Responsive Mutation Status COMPLETED Phase PHASE3
NCT03273959 Program Of Exercises During The Hospitalization Of Children And Adolescents With Cystic Fibrosis Status UNKNOWN Phase NA
NCT03265288 Study of LAU-7b in the Treatment of Cystic Fibrosis in Adults Status COMPLETED Phase PHASE2
NCT03264950 Utility of Point Shear-wave Elastography to Assess for Hepatic & Pancreatic Fibrosis in Pediatric CF Patients Status UNKNOWN Phase NA
NCT03258424 Study Assessing PTI-428 Safety, Tolerability, and Pharmacokinetics in Subjects With Cystic Fibrosis on KALYDECO® as Background Therapy Status COMPLETED Phase PHASE1
NCT03256968 PTC Study to Evaluate Ataluren in Combination With Ivacaftor Status COMPLETED Phase PHASE4
NCT03256799 Evaluation of Ivacaftor in Patients Using Ataluren for Nonsense Mutations Status COMPLETED Phase PHASE4
NCT03229252 An Efficacy and Safety Study of SPX-101 Inhalation Solution in Subjects With Cystic Fibrosis Status COMPLETED Phase PHASE2
NCT03227471 A Study of VX-445 in Healthy Subjects and Subjects With Cystic Fibrosis Status COMPLETED Phase PHASE1/PHASE2
NCT03226795 Improving Therapeutic Adherence With a Co-constructed Program Involving Both Patients and Health Care Professionals Status UNKNOWN Phase NA